Aurantio-obtusin is a natural osteoanabolic agent that promotes osteoblast migration, differentiation, and mineralization in vitro. It also modulates drug metabolism by inhibiting SN-38 glucuronidation, impacting irinotecan toxicity, making it relevant for osteoporosis and pharmacokinetics research.